Back to results
US 8,912,208 B2Granted
(4-{4-[5-(benzooxazol-2-ylamino)-pyridin-2-yl]-phenyl}-cyclohexyl)-acetic acid useful for treating or preventing conditions or disorders associated with DGAT1 activity
AssigneeNovartis AG
InventorsMichael H. Serrano-Wu, Young-shin Kwak, Wenming Liu
Life of this patent
Estimating the term…
Abstract
The present invention provides (4-{4-[5-(Benzooxazol-2-ylamino)-pyridin-2-yl]-phenyl}-cyclohexyl)-acetic acid which is useful for treating or preventing conditions or disorders associated with DGAT1 activity in animals, particularly humans.
Claims6
The compound:
- or a pharmaceutically acceptable salt thereof.
The compound:
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.